Corporate

New research shows marked differences between Hispanic and non-Hispanic type 2 diabetes patients in disease perceptions and management approaches, highlighting need for tailored education among patients and healthcare professionals

Ultrasonic device known for meticulous dissection now produces lower tissue temperature and less thermal damage critical when working near nerves

Results served as basis for regulatory filing with U.S. Food and Drug Administration and designation as Priority Review

Findings Add to Existing Research Showing XARELTO® Cost-Savings Value Across Multiple Indications

Strategic Collaboration Designed to Develop New Technologies that Offer Surgeons and Health Care Systems Greater Accuracy, Cost Efficiency and Better Outcomes for Patients

Independent Data Monitoring Committee determines HELIOS study meets its primary endpoint of progression-free survival in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma at a pre-planned interim analysis

New Patient Athlete™ Program Demonstrates Comprehensive Approach to Driving Sustained Behavior Change and Improved Outcomes

New Focus in Disease Prevention, Disease Interception, and the Microbiome to Propel Scientific Innovation

Visualization Platform Technology and Expertise to Broaden Arthroscopy Portfolio